Oxervate (cenegermin-bkbj) — Point32Health
neurotrophic keratitis, stage 2 or 3
Initial criteria
- Documented diagnosis of stage 2 or 3 neurotrophic keratitis
- Prescribed by an ophthalmologist
- Documented trial and failure with one (1) conventional non-surgical treatment for neurotrophic keratitis (e.g., preservative-free artificial tears, gels, or ointments; discontinuation of preserved topical drops and medications that can decrease corneal sensitivity; therapeutic contact lenses)
Reauthorization criteria
- Additional treatment beyond 8-weeks will not be authorized
Approval duration
8 weeks (one-time course per affected eye)